Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
21/11/2023 13:14
Nov 21 (Reuters) - Orchard Therapeutics PLC OT10y.F :
* ORCHARD THERAPEUTICS-ON NOV 15, U.S. FDA ADVISED CO IT
DOES NOT
INTEND TO SCHEDULE ADVISORY COMMITTEE MEETING
* ORCHARD THERAPEUTICS-FDA TO NOT SCHEDULE MEETING IN
CONNECTION
WITH FDA'S REVIEW OF CO'S BLA FOR COMMERCIAL MARKETING & SALE OF
OTL-200 IN U.S
Further company coverage: OT10y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln